Liraglutide, the once-daily human GLP-1 analogue, has a protracted profile based on both delayed absoprtion and a long plasma half-life

被引：0

作者：

Knudsen, L. Bjerre ^{[1
]}

Nielsen, P. F. ^{[1
]}

Steensgaard, D. B. ^{[1
]}

Bloch, P. ^{[1
]}

Lau, J. ^{[1
]}

Agersoe, H. ^{[1
]}

机构：

[1] Novo Nordisk AS, Malov, Denmark

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

775

引用

页码：S305 / S306

页数：2

共 50 条

[1] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
Kapitza, Christoph
Flint, Anne
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A593 - A593
[2] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
Russell-Jones, David
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
[3] The molecular basis for the delayed absorption of the once-daily human GLP-1 analoge, liraglutide
Steensgaard, Dorte B.
Thomsen, Jens K.
Olsen, Helle B.
Knudsen, Lotte B.
DIABETES, 2008, 57 : A164 - A164
[4] The once-daily human GLP-1 analogue liraglutide decreases postprandial hunger and energy intake
Flint, Anne
Kapitza, Christoph
Hinds-Berger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A165 - A165
[5] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
Flint, A.
Kapitza, C.
Hindsberger, C.
Zdravkovic, M.
DIABETOLOGIA, 2008, 51 : S354 - S354
[6] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
Flint, Anne
Kapitza, Christoph
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A165 - A165
[7] Mechanism of Protraction for Liraglutide, the Once-Daily Human GLP-1 Analog
Knudsen, Lotte B.
Nielsen, Per F.
Steensgaard, Dorte B.
Bloch, Paw
Lau, Jesper
Agersoe, Henrik
DIABETES, 2009, 58 : A532 - A532
[8] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
Vilsboll, Tina
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
[9] The effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide
Kapitza, Christoph
Flint, Anne
Spitzer, Heike
Hindsberger, Charlotte
Zdravkovic, Milan
DIABETES, 2008, 57 : A593 - A593
[10] Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide
Kapitza, Christoph
Zdravkovic, Milan
Zijlstra, Eric
Segel, Stine
Heise, Tim
Flint, Anne
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06): : 951 - 955

← 1 2 3 4 5 →